We have frequently observed a subty

We have frequently observed a subtype of VVC,
common in vulvar disease clinics, in which
patients’ symptoms are continuous rather than discretely
episodic. In a vulvar clinic situation, acute and even recurrent
VVC is rarely encountered and we, therefore,
presume it is being successfully managed in primary
care. In contrast to recurrent vulvovaginal candidiasis
(RVVC) where patients are asymptomatic between discrete
attacks, this third group has an as-yet undefined and
uncharacterized condition that we have termed chronic
vulvovaginal candidiasis (CVVC). In this condition, patients
present with chronic, continuous symptoms, which
improve during menses and remit with antifungal therapy,
often recurring when this is ceased, particularly after
short course therapy. We have also observed that vaginal
swabs do not invariably demonstrate Candida at presentation
even in the presence of intense symptoms and
obvious signs and that insisting on this as a diagnostic criterion would limit our ability to identify and correctly
treat this condition.
Vulvovaginal candidiasis (VVC) is defined as vulvovaginitis
causally related to vaginal carriage of Candida
species and is a common problem associated with a high
level of morbidity. The burden of cost to the community
is significant and has been estimated at $1.8 billion per
year in the United States [1, 2]. Topical and oral antifungal
medications are readily available over the counter.
Many women self-medicate, generating extra costs in
medication use and false-negatives when medication has
been used before microbiologic confirmation.

Hasil (Bahasa Indonesia) 1:

Kami telah sering mengamati subtipe dari VVC,umum di vulva penyakit klinik, di manapasien gejala terus-menerus daripada discretelyepisodik. Dalam situasi vulva klinik, akut dan bahkan berulangVVC jarang ditemui dan kami, oleh karena itu,menganggap ini berhasil dikelola di dasarperawatan. Berbeda dengan vulvovaginal berulang kandidiasis(RVVC) dimana pasien asimtomatik antara diskritserangan, kelompok ketiga ini telah sebagai-belum terdefinisi danuncharacterized kondisi yang kita telah dipanggil kronisVulvovaginal kandidiasis (CVVC). Dalam kondisi ini, pasienhadir dengan gejala kronis, terus menerus, yangmeningkatkan selama haid dan mengirimkan dengan terapi antijamur,sering berulang saat ini adalah berhenti, terutama setelahkursus singkat terapi. Kami juga telah mengamati bahwa vaginapenyeka tidak selalu menunjukkan Candida di presentasibahkan di hadapan intens gejala dantanda-tanda jelas dan bersikeras bahwa ini sebagai kriteria diagnostik akan membatasi kemampuan kita untuk mengidentifikasi dan benarmengobati kondisi ini.Kandidiasis Vulvovaginal (VVC) didefinisikan sebagai Trichomonaisiskausal yang berkaitan dengan vagina pengangkutan Candidaspesies dan adalah masalah umum yang terkait dengan tinggitingkat morbiditas. Beban biaya kepada masyarakatsignifikan dan telah diperkirakan pada $1,8 milyar pertahun di Amerika Serikat [1, 2]. Topikal dan oral antijamurobat tersedia di atas meja.Banyak wanita yang mengobati diri, menghasilkan biaya tambahanmenggunakan pengobatan dan palsu negatif ketika obattelah digunakan sebelum konfirmasi microbiologic.